SPIRIVA 18mcg capsules with inhalation powder medication leaflet

R03BB04 tiotropium • Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics

Tiotropium is a bronchodilator used for the treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by blocking muscarinic receptors in the airways, relaxing the muscles and making breathing easier.

The medication is administered via inhaler, usually once daily, as directed by a doctor. It is used for long-term control of symptoms and not for quick relief of breathing crises.

Patients should strictly follow the instructions for using the inhaler and inform their doctor of any unusual symptoms. It is important not to exceed the recommended dose.

Side effects may include dry mouth, cough, throat irritation, and, in rare cases, severe allergic reactions or breathing difficulties. Patients should be informed of these risks before starting treatment.

SPIRIVA 18mcg capsules with inhalation powder BOEHRINGER, tiotropium

General data about SPIRIVA 18mcg

Substance: tiotropium

Date of last drug list: 01-05-2026

Commercial code: W57488004

Concentration: 18mcg

Pharmaceutical form: capsules with inhalation powder

Quantity: 30

Product type: original

Price: 102.74 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA

Holder: BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA

Number: 9766/2017/02

Shelf life: 2 years; 9 days-after the first opening a blist.; 12 months-dupa prima utilizare a dispozitivului HandiHal

Concentrations available for tiotropium

10mcg, 18mcg, 2.5mcg

Combinations with other substances

Compensation lists for SPIRIVA 18mcg Boehringer

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

102.74 RON

51.37 RON

51.37 RON